welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Single-Incision Laparoscopic Ileal Pouch-Anal Anastomosis in Children–How Does it Compare to a Laparoscopic-Assisted Approach?
source: Journal of laparoendoscopic & advanced surgical techniques
year: 2014
authors: Polites S F, Zarroug A E, Moir C R, Potter D D
summary/abstract:BACKGROUND : Although single-incision laparoscopic (SIL) ileal pouch-anal anastomosis (IPAA) has been shown to be feasible and safe, outcomes have not been compared with the standard laparoscopic-assisted (LA) procedures. The purpose of this study was to compare the two techniques in children with chronic ulcerative colitis (CUC) and familial adenomatous polyposis (FAP).
SUBJECTS AND METHODS : Children ≤ 18 years of age who underwent SIL and LA IPAA between 2000 and 2013 at our institution were identified. Patient information was obtained retrospectively from patients’ medical records and compared between approaches. RESULTS for operative time and postoperative length of stay were stratified by number of stages (one, two, or three), and postoperative complications were stratified by diagnosis (CUC or FAP).
RESULTS : Children who underwent SIL IPAA (n=19) and LA IPAA (n=62) were not significantly different in age, gender, diagnosis, anti-tumor necrosis factor-α antibody use, staged approach, and stapled versus mucosectomy with hand-sewn anastomosis. SIL and LA IPAA had equivalent operative times for two- and three-stage procedures, but operative time for one-stage procedures was shorter with SIL (308 versus 355 minutes; P<.001). Median length of stay was shorter following SIL for all patients (4 versus 7 days; P<.001) and, specifically, for two-stage patients (4 versus 6 days; P=.009). There were no significant differences in complications between SIL and LA.
CONCLUSIONS : SIL IPAA is a safe alternative to LA IPAA for children with CUC or FAP and may reduce postoperative length of stay without affecting short-term postoperative morbidity. Additional studies are needed to determine if there are long-term benefits.
organization: Mayo ClinicDOI: 10.1089/lap.2014.0297
read more full text source
expertly curated content related to this topic
-
Early Onset of Dysplasia in Polyps in Children with Familial Adenomatous Polyposis: Case Report and Literature Revie...Familial adenomatous polyposis (FAP) is ...
-
Gardner Syndrome: Skin Manifestations, Differential Diagnosis and ManagementGardner syndrome is a variant of familia...
-
Woman with Ostomy Bag Refused Entry to Bathroom with Disability AccessThat’s the message English blogger Sam...
-
A Study of Guselkumab in Participants With Familial Adenomatous PolyposisThe purpose of this study is to determin...
-
Victoria’s OTHER Secret: Designer Creates World’s first Lingerie Colostomy Bags as They often Put Partners OffA young designer has taken fashion into ...
-
Phase I Trial of Exisulind (Sulindac Sulfone, FGN-1) as a Chemopreventive Agent in Patients with Familial Adenomatou...Exisulind (sulindac sulfone; FGN-1), a m...
-
Inflammatory Bowel Disease and Familial Adenomatous Polyposis Clinical Management and Patients’ Quality of LifeInflammatory bowel disease (IBD) and fam...
English
Portuguese
Spanish